The global burden
of bacterial infection and antimicrobial resistance
increases the demand to associate more than one antibiotic to fight
life-threatening bacteria. Therefore, there is a great necessity to
develop simple and sensitive methods for routine analysis of clinical
samples. Therapeutic drug monitoring, bioequivalence, and pharmacokinetic
studies are essential to ensure drug efficiency and safety. Herein,
therefore, the first ecofriendly liquid chromatography −tandem
mass spectrometry (LC–MS/MS) method was developed and fully
validated for simultaneous determination of a commonly combined antibiotic
for methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin (VCM) and gentamicin (GTM), in rat plasma after parenteral
administration. VCM and GTM were extracted from plasma sample using
acetonitrile (ACN)/0.1% TFA-induced protein precipitation followed
by the separation on an Agilent Eclipse Plus ODS (3 mm × 100
mm, 3.5 μm) column using water-enriched mobile phase consisting
of water containing 0.1% THF/ACN (85:15, v/v%) at flow rates of 0.30
mL min–1. The mass spectrometry parameters were
optimized, and multiple reaction monitoring (MRM) in positive ion
mode of two transitions was utilized for quantification of precursor
to product ion at m/z 725.5 →
144 and 100.1 for VCM as [M + 2H]2+, 478.3 → 322.2
and 156.9 for GTM, and 586.3 → 162.9 and 425.3 for amikacin
(AMK) internal standard, as [M + H]+. The current method
has been validated as per U.S. FDA bioanalytical guidelines in terms
of linearity, accuracy, precision, selectivity, recovery, matrix effects,
and stability. The method was linear in the range of 1–2000
ng mL–1 and 1–1000 ng mL–1 with detection limits (S/N of 3) of 0.18 and 0.09 ng mL–1 for VCM and GTM, respectively. The selectivity and high sensitivity
allow the current method to succeed in the study of pharmacokinetic
parameters and drug–drug interaction between VCM and GTM after
single-dose administration. VCM increased plasma clearance and elimination
rate constant of GTM when coadministered and GTM also too. The change
of serum chemistry analysis and significant elevation of creatinine
and BUN indicate an alteration in kidney function in group III in
those given the combined antibiotics. Our finding illustrated the
nephrotoxicity of the two drugs when associated. The ecofriendly,
simplicity, and rapidity of the current study made it a promising
method for high-throughput biomonitoring in clinical samples.